Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial

OBJECTIVES: A severe epidemic of COVID-19 has broken out in China and has become a major global public health event. We focus on the Acute Respiratory Distress Syndrome (ARDS)-like changes and overactivation of Th17 cells (these produce cytokines) in patients with COVID-19. We aim to explore the saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Panpan, Huang, Zhijun, Yin, Mingzhu, Liu, Chun, Chen, Xiang, Pan, Pinhua, Kuang, Yehong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716285/
https://www.ncbi.nlm.nih.gov/pubmed/33276811
http://dx.doi.org/10.1186/s13063-020-04925-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716285/
https://www.ncbi.nlm.nih.gov/pubmed/33276811
http://dx.doi.org/10.1186/s13063-020-04925-8

Ejemplares similares